Randomized Phase II Study of Everolimus (E) Versus Everolimus plus Bevacizumab (E plus B) in Patients (Pts) With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kulke, MH; Niedzwiecki, D; Foster, NR; Fruth, B; Kunz, PL; Kennecke, H; Wolin, EM; Venook, AP

Published Date

  • March 1, 2016

Published In

Volume / Issue

  • 45 / 3

Start / End Page

  • 477 - 477

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1536-4828

International Standard Serial Number (ISSN)

  • 0885-3177

Language

  • English